GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,160,000 | +0.2% | 7,486 | -59.5% | 0.06% | +3.6% |
| Q4 2020 | $1,158,000 | -4.8% | 18,502 | -2.1% | 0.06% | -26.7% |
| Q3 2020 | $1,216,000 | +14.7% | 18,902 | +13.3% | 0.08% | +7.1% |
| Q2 2020 | $1,060,000 | -12.3% | 16,676 | -29.7% | 0.07% | +12.9% |
| Q1 2020 | $1,208,000 | +133.2% | 23,725 | -4.7% | 0.06% | +100.0% |
| Q4 2019 | $518,000 | -34.4% | 24,901 | -41.7% | 0.03% | -56.9% |
| Q3 2019 | $790,000 | +259.1% | 42,700 | +151.2% | 0.07% | +260.0% |
| Q2 2019 | $220,000 | -31.7% | 17,000 | +134.4% | 0.02% | -39.4% |
| Q1 2019 | $322,000 | -42.5% | 7,252 | -78.1% | 0.03% | -37.7% |
| Q4 2018 | $560,000 | -51.1% | 33,164 | -0.7% | 0.05% | -32.9% |
| Q3 2018 | $1,145,000 | +16.5% | 33,400 | +39.1% | 0.08% | +1.3% |
| Q2 2018 | $983,000 | +10.7% | 24,003 | -30.2% | 0.08% | +1.3% |
| Q1 2018 | $888,000 | -28.4% | 34,403 | -66.7% | 0.08% | +51.0% |
| Q4 2017 | $1,240,000 | +5.9% | 103,300 | -9.0% | 0.05% | +15.9% |
| Q3 2017 | $1,171,000 | -30.7% | 113,511 | -14.4% | 0.04% | -29.0% |
| Q2 2017 | $1,690,000 | -48.6% | 132,674 | -40.1% | 0.06% | -54.7% |
| Q1 2017 | $3,291,000 | +7.7% | 221,547 | -43.6% | 0.14% | +24.5% |
| Q4 2016 | $3,057,000 | -53.6% | 393,130 | -10.7% | 0.11% | -62.8% |
| Q3 2016 | $6,592,000 | +29.8% | 439,990 | +27.9% | 0.30% | +14.3% |
| Q2 2016 | $5,077,000 | +16.2% | 344,072 | -11.6% | 0.26% | -10.1% |
| Q1 2016 | $4,370,000 | +39.7% | 389,081 | +64.2% | 0.29% | +64.6% |
| Q4 2015 | $3,129,000 | – | 236,980 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|